Radio-guided localization of clinically occult breast lesions: current modalities and future directions

References

• Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch. Surg. 131(3), 301–308 (1996).
   PubMedGoogle Scholar
• McLelland R. Screening mammography. Cancer 67(4 Suppl.), 1129–1131 (1991).
   PubMedGoogle Scholar
• Goedde TA, Frykberg ER, Crump JM, Lay SF, Turetsky DB, Linden SS. The impact of mammography on breast biopsy. Am. Surg. 58(11), 661–666 (1992).
   PubMedGoogle Scholar
• Lui CY, Lam HS, Chan LK et al. Opportunistic breast cancer screening in Hong Kong; a revisit of the Kwong Wah Hospital experience. Hong Kong Med. J. 13(2), 106–113 (2007).
   PubMedGoogle Scholar
• Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann. Surg. Oncol. 9(10), 994–998 (2002).
   PubMed Web of Science ®Google Scholar
• Phillips N, Coldman A. Comparison of nonbreast cancer incidence, survival and mortality between breast screening program participants and nonparticipants. Int. J. Cancer 122(1), 197–201 (2008).
   PubMedGoogle Scholar
• Harris JR, Botnick L, Bloomer WD, Chaffey JT, Hellman S. Primary radiation therapy for early breast cancer: the experience at The Joint Center for Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys. 7(11), 1549–1552 (1981).
   PubMedGoogle Scholar
• Bartelink H, Horiot JC, Poortmans P et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N. Engl. J. Med. 345(19), 1378–1387 (2001).
   PubMedGoogle Scholar
• Hirsch JI, Banks WL Jr, Sullivan JS, Horsley JS, 3rd. Effect of methylene blue on estrogen-receptor activity. Radiology 171(1), 105–107 (1989).
   PubMedGoogle Scholar
• Luini A, Zurrida S, Galimberti V, Paganelli G. Radioguided surgery of occult breast lesions. Eur. J. Cancer 34(1), 204–205 (1998).
   PubMedGoogle Scholar
• Rose A, Collins JP, Neerhut P, Bishop CV, Mann GB. Carbon localisation of impalpable breast lesions. Breast 12(4), 264–269 (2003).
   PubMedGoogle Scholar
• Tafra L, Fine R, Whitworth P et al. Prospective randomized study comparing cryo-assisted and needle-wire localization of ultrasound-visible breast tumors. Am. J. Surg. 192(4), 462–470 (2006).
   PubMedGoogle Scholar
• Tromberg BJ, Pogue BW, Paulsen KD, Yodh AG, Boas DA, Cerussi AE. Assessing the future of diffuse optical imaging technologies for breast cancer management. Med. Phys. 35(6), 2443–2451 (2008).
   PubMedGoogle Scholar
• della Rovere GQ, Benson JR, Morgan M, Warren R, Patel A. Localization of impalpable breast lesions--a surgical approach. Eur. J. Surg. Oncol. 22(5), 478–482 (1996).
   PubMedGoogle Scholar
• Homer MJ, Smith TJ, Safaii H. Prebiopsy needle localization. Methods, problems, and expected results. Radio. Clin. North Am. 30(1), 139–153 (1992).
   PubMedGoogle Scholar
• Rappaport W, Thompson S, Wong R, Leong S, Villar H. Complications associated with needle localization biopsy of the breast. Surg. Gynecol. Obstet. 172(4), 303–306 (1991).
   PubMedGoogle Scholar
• Luini A, Zurrida S, Paganelli G et al. Comparison of radioguided excision with wire localization of occult breast lesions. Br. J. Surg. 86(4), 522–525 (1999).
   PubMedGoogle Scholar
• Chu TY, Lui CY, Hung WK, Kei SK, Choi CL, Lam HS. Localisation of occult breast lesion: a comparative analysis of hookwire and radioguided procedures. Hong Kong Med. J. 16(5), 367–372 (2010).
   PubMedGoogle Scholar
• Buchberger W, Niehoff A, Obrist P, DeKoekkoek-Doll P, Dunser M. Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin. Ultrasound CT MR 21(4), 325–336 (2000).
   PubMedGoogle Scholar
• De Cicco C, Trifiro G, Intra M et al. Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions. Eur J Nucl Med Mol Imaging, 31(3), 349–354 (2004).
   PubMedGoogle Scholar
• Nadeem R, Chagla LS, Harris O et al. Occult breast lesions: A comparison between radioguided occult lesion localisation (ROLL) vs. wire-guided lumpectomy (WGL). Breast 14(4), 283–289 (2005).
   PubMedGoogle Scholar
• Seifi A, Axelrod H, Nascimento T et al. Migration of guidewire after surgical breast biopsy: an unusual case report. Cardiovascular and interventional radiology, 32(5), 1087–1090 (2009).
   PubMedGoogle Scholar
• Postma EL, Koffijberg H, Verkooijen HM, Witkamp AJ, van den Bosch MA, van Hillegersberg R. Cost-effectiveness of radioguided occult lesion localization (ROLL) versus wire-guided localization (WGL) in breast conserving surgery for nonpalpable breast cancer: results from a randomized controlled multicenter trial. Ann. Surg. Oncol. (2013).
   PubMedGoogle Scholar
• Paganelli G, Luini A, Veronesi U. Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation. Ann. Oncol. 13(12), 1839–1840 (2002).
   PubMedGoogle Scholar
• De Cicco C, Pizzamiglio M, Trifiro G et al. Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects. Q J. Nucl. Med. 46(2), 145–151 (2002).
   PubMedGoogle Scholar
• Landheer ML, Klinkenbijl JH, Pasker-de Jong PC, Wobbes T. Residual disease after excision of non-palpable breast tumours: analysis of tumour characteristics. Eur. J. Surg. Oncol. 30(8), 824–828 (2004).
   PubMedGoogle Scholar
• Dua SM, Gray RJ, Keshtgar M. Strategies for localisation of impalpable breast lesions. Breast 20(3), 246–253 (2011).
   PubMedGoogle Scholar
• James JJ, Wilson AR, Evans AJ, Burrell H, Cornford EJ, Hamilton LJ. The use of a short-acting benzodiazepine to reduce the risk of syncopal episodes during upright stereotactic breast biopsy. Clin. Radiol. 60(3), 394–396 (2005).
   PubMedGoogle Scholar
• Medina-Franco H, Abarca-Perez L, Ulloa-Gomez JL, Romero C. Radioguided localization of clinically occult breast lesions (ROLL): a pilot study. Breast J. 13(4), 401–405 (2007).
   PubMedGoogle Scholar
• Yilmaz MH, Kilic F, Icten GE et al. Radio-guided occult lesion localisation for breast lesions under computer-aided MRI guidance: the first experience and initial results. Br. J. Radiol. 85(1012), 395–402 (2012).
   PubMedGoogle Scholar
• Intra M, de Cicco C, Gentilini O, Luini A, Paganelli G. Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): the experience of the European Institute of Oncology. Eur. J. Nucl. Med. Mol. Imaging 34(6), 957–958 (2007).
   PubMedGoogle Scholar
• Monti S, Galimberti V, Trifiro G et al. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann. Surg. Oncol. 14(10), 2928–2931 (2007).
   PubMed Web of Science ®Google Scholar
• Moreno M, Wiltgen JE, Bodanese B, Schmitt RL, Gutfilen B, da Fonseca LM. Radioguided breast surgery for occult lesion localization – correlation between two methods. J. Exp. Clin. Cancer Res. 27, 29 (2008).
   PubMedGoogle Scholar
• Mariscal Martinez A, Sola M, de Tudela AP et al. Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. AJR. Am. J. Roentgenol. 193(4), 1001–1009 (2009).
   PubMedGoogle Scholar
• Thind CR, Desmond S, Harris O, Nadeem R, Chagla LS, Audisio RA. Radio-guided localization of clinically occult breast lesions (ROLL): a DGH experience. Clin. Radiol. 60(6), 681–686 (2005).
   PubMedGoogle Scholar
• Medina-Franco H, Abarca-Perez L, Garcia-Alvarez MN, Ulloa-Gomez JL, Romero-Trejo C, Sepulveda-Mendez J. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation. J. Surg. Oncol. 97(2), 108–111 (2008).
   PubMedGoogle Scholar
• Rampaul RS, Bagnall M, Burrell H, Pinder SE, Evans AJ, Macmillan RD. Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br. J. Sur. 91(12), 1575–1577 (2004).
   PubMedGoogle Scholar
• Tanis PJ, Nieweg OE, Valdes Olmos RA, Hoefnagel CA. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation. Eur. J. Nucl. Med. Mol. Imaging 29(3), 436–437, author reply 437–438 (2002).
   PubMedGoogle Scholar
• Tanis PJ, Deurloo EE, Valdes Olmos RA et al. Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node. Ann. Surg. Oncol. 8(10), 850–855 (2001).
   PubMedGoogle Scholar
• Aydogan F, Ozben V, Celik V et al. Radioguided occult lesion localization (ROLL) for non-palpable breast cancer: a comparison between day-before and same-day protocols. Breast 19(3), 226–230 (2010).
   PubMedGoogle Scholar
• Morris EA, Liberman L, Dershaw DD et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am. J. Roentgenol. 178(5), 1211–1220 (2002).
   PubMedGoogle Scholar
• Ronka R, Krogerus L, Leppanen E, von Smitten K, Leidenius M. Radio-guided occult lesion localization in patients undergoing breast-conserving surgery and sentinel node biopsy. Am. J. Surg. 187(4), 491–496 (2004).
   PubMedGoogle Scholar
• Gray RJ, Salud C, Nguyen K et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann. Surg. Oncol. 8(9), 711–715 (2001).
   PubMedGoogle Scholar
• Sajid MS, Parampalli U, Haider Z, Bonomi R. Comparison of radioguided occult lesion localization (ROLL) and wire localization for non-palpable breast cancers: a meta-analysis. J. Surg. Oncol. 105(8), 852–858 (2012).
   PubMedGoogle Scholar
• Cremonesi M, Ferrari M, Sacco E et al. Radiation protection in radioguided surgery of breast cancer. Nuclear Med. Commun. 20(10), 919–924 (1999).
   PubMedGoogle Scholar
• Rampaul RS, Dudley NJ, Thompson JZ et al. Radioisotope for occult lesion localisation (ROLL) of the breast does not require extra radiation protection procedures. Breast 12(2), 150–152 (2003).
   PubMedGoogle Scholar
• Ramesh HS, Anguille S, Chagla LS et al. Recurrence after ROLL lumpectomy for invasive breast cancer. Breast 17(6), 637–639 (2008).
   PubMedGoogle Scholar
• Silverstein MJ, Gamagami P, Rosser RJ et al. Hooked-wire-directed breast biopsy and overpenetrated mammography. Cancer 59(4), 715–722 (1987).
   PubMedGoogle Scholar
• Liberman L, Kaplan J, Van Zee KJ et al. Bracketing wires for preoperative breast needle localization. AJR Am. J. Roentgenol. 177(3), 565–572 (2001).
   PubMedGoogle Scholar
• Rampaul RS, MacMillan RD, Evans AJ. Intraductal injection of the breast: a potential pitfall of radioisotope occult lesion localization. Br. J. Radiol. 76(906), 425–426 (2003).
   PubMedGoogle Scholar
• Aydogan F, Celik V, Uras C et al. Radioguided occult lesion localization (ROLL) of the nonpalpable breast lesions. Ulusal Cerrahi Dergisi 25(1), 24–28 (2009).
   Google Scholar
• Zgajnar J, Hocevar M, Frkovic-Grazio S, Hertl K, Schweiger E, Besic N. Radioguided occult lesion localization (ROLL) of the nonpalpable breast lesions. Neoplasma 51(5), 385–389 (2004).
   PubMedGoogle Scholar
• Fraile M, Mariscal A, Lorenzo C et al. [Radio-guided occult lesion localization combined with sentinel node biopsy in women with breast cancer]. Cirugia Espanola 77(1), 36–39 (2005).
   PubMedGoogle Scholar
• Krekel NM, Zonderhuis BM, Stockmann HB et al. A comparison of three methods for nonpalpable breast cancer excision. Eur. J. Surg. Oncol. 37(2), 109–115 (2011).
   PubMed Web of Science ®Google Scholar
• Ocal K, Dag A, Turkmenoglu O, Gunay EC, Yucel E, Duce MN. Radioguided occult lesion localization versus wire-guided localization for non-palpable breast lesions: randomized controlled trial. Clinics (Sao Paulo) 66(6), 1003–1007 (2011).
   PubMedGoogle Scholar
• Takacs T, Paszt A, Simonka Z et al. Radioguided occult lesion localisation versus wire-guided lumpectomy in the treatment of non-palpable breast lesions. Pathol. Oncol. Res. 19(2), 267–273 (2013).
   PubMedGoogle Scholar
• Postma EL, Verkooijen HM, van Esser S et al. Efficacy of ‘radioguided occult lesion localisation’ (ROLL) versus ‘wire-guided localisation’ (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res. Treat. 136(2), 469–478 (2012).
   PubMedGoogle Scholar
• Paganelli G, Gilardi L, Veronesi U. Improper use of “radioguided occult lesion localization” (ROLL) technique leads to misleading conclusions. Breast Cancer Res. Treat. 139(1), 287–288 (2013).
   PubMedGoogle Scholar
• Schulze T, Bembenek A, Schlag PM. Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbeck’s Arch. Surg. 389(6), 532–550 (2004).
   PubMedGoogle Scholar
• Strong VE, Humm J, Russo P et al. A novel method to localize antibody-targeted cancer deposits intraoperatively using handheld PET beta and gamma probes. Surgical Endosc. 22(2), 386–391 (2008).
   PubMed Web of Science ®Google Scholar
• Kumar R, Alavi A. Fluorodeoxyglucose-PET in the management of breast cancer. Radiol. Clin. North Am. 42(6), 1113–1122, ix (2004).
   PubMedGoogle Scholar
• Pleijhuis RG, Graafland M, de Vries J, Bart J, de Jong JS, van Dam GM. Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann. Surg. Oncol. 16(10), 2717–2730 (2009).
   PubMedGoogle Scholar
• Luker GD, Luker KE. Optical imaging: current applications and future directions. J. Nuclear Med. 49(1), 1–4 (2008).
   PubMedGoogle Scholar
• von Burstin J, Eser S, Seidler B et al. Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice. Int. J. Cancer 123(9), 2138–2147 (2008).
   PubMed Web of Science ®Google Scholar
• Tagaya N, Yamazaki R, Nakagawa A et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am. J. Surg. 195(6), 850–853 (2008).
   PubMedGoogle Scholar
• Backer MV, Levashova Z, Patel V et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat. Med. 13(4), 504–509 (2007).
   PubMedGoogle Scholar
• Stanciute D, Didziapetriene J, Kadziauskas J. [Expression of matrix metalloproteinases in patients with malignant tumors]. Medicina (Kaunas), 40(12), 1143–1150 (2004).
   PubMedGoogle Scholar
• Tung CH, Mahmood U, Bredow S, Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 60(17), 4953–4958 (2000).
   PubMed Web of Science ®Google Scholar
• Kirsch DG, Dinulescu DM, Miller JB et al. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat. Med. 13(8), 992–997 (2007).
   PubMedGoogle Scholar
• Cox C, Centeno B, Dickson D et al. Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma. Cancer 105(1), 13–20 (2005).
   PubMedGoogle Scholar
• Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non palpable breast lesions. Am. J. Surg. 199(4), 522–528 (2010).
   PubMedGoogle Scholar
• Hughes JH, Mason MC, Gray RJ et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J. 14(2), 153–157 (2008).
   PubMedGoogle Scholar
• Lovrics PJ, Goldsmith CH, Hodgson N et al. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas. Ann. Surg. Oncol. 18(12), 3407–3414 (2011).
   PubMedGoogle Scholar
• van Riet YE, Jansen FH, van Beek M, van de Velde CJ, Rutten HJ, Nieuwenhuijzen GA. Localization of non-palpable breast cancer using a radiolabelled titanium seed. Br. J. Surg. 97(8), 1240–1245 (2010).
   PubMedGoogle Scholar
• Lovrics PJ, Cornacchi SD, Vora R, Goldsmith CH, Kahnamoui K. Systematic review of radioguided surgery for non-palpable breast cancer. Eur. J. Surg. Oncol. 37(5), 388–397 (2011).
   PubMed Web of Science ®Google Scholar
• Postma EL, Witkamp AJ, van den Bosch MA, Verkooijen HM, van Hillegersberg R. Localization of nonpalpable breast lesions. Expert Rev. Anticancer Ther. 11(8), 1295–1302 (2011).
   PubMed Web of Science ®Google Scholar
• Valdes Olmos RA, Vidal-Sicart S, Nieweg OE. Technological innovation in the sentinel node procedure: towards 3-D intraoperative imaging. Eur. J. Nucl. Med. Mol. Imaging, 37(8), 1449–1451 (2010).
   PubMedGoogle Scholar
• Naji S, Tadros A, Traub J, Healy C. Case report: improving the speed and accuracy of melanoma sentinel node biopsy with 3D intra-operative imaging. J. Plast. Reconstr. Aesthet. Surg. 64(12), 1712–1715 (2011).
   PubMedGoogle Scholar
• Bluemel C, Schnelzer A, Okur A et al. Freehand SPECT for image-guided sentinel lymph node biopsy in breast cancer. Eur. J. Nucl. Med. Mol. Imaging 40(11), 1656–1661 (2013).
   PubMed Web of Science ®Google Scholar
• Aydogan F, Ozben V, Aytac E, Yilmaz H, Cercel A, Celik V. Excision of nonpalpable breast cancer with indocyanine green fluorescence-guided occult lesion localization (IFOLL). Breast Care (Basel) 7(1), 48–51 (2012).
   PubMedGoogle Scholar